Mullica Hill-based Inspira Health’s pharmacy teams are making hand sanitizer for use in its medical facilities to fend off shortages caused by COVID-19.
With the supply of commercially produced hand sanitizer very limited, Inspira is targeting to produce 50 percent, or more, of the hand sanitizer used across the health system.
Inspira set a process in motion to produce the alcohol-based product within days of the U.S. Food and Drug Administration granting pharmacists temporary permission to do so.
According to Inspira Health, hand sanitizer has become an indispensable hygiene component in health care facilities, and plays a critical role in keeping patients and staff safe. A nurse working a 12-hour shift, for example, would likely need to clean her hands more than 100 times.
“Exploring innovative solutions and new methods are core tenets of Inspira Health’s culture,” said John DiAngelo, president and chief executive officer of Inspira Health. “I am immensely proud of how swiftly and efficiently our pharmacy teams have been able to produce and supply hand sanitizer for our organization in the midst of this unprecedented emergency. Initiatives like this are of utmost importance because they support the safety of our patients, staff and physicians, across our network.”
Throughout the production process, all Inspira Health employees are following proper safety protocols, including wearing personal protective equipment.
For quality assurance, each batch is tested with a refractometer to ensure the alcohol content meets FDA guidelines for hand sanitizer. Making alcohol-based hand sanitizer can be dangerous and should not be attempted by the general public.